SLC22A1 and hepatocellular carcinoma: They used this system to deliver different types of siRNA, and effectively knocked down GAPDH, PEPCK (a rate-limiting enzyme for gluconeogenesis), and organic cation transporter 1 (OCT1), reducing the glucose production of rat hepatoma H4IIEC3 cells [62].